Matinas BioPharma

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MTNB and other ETFs, options, and stocks.

About MTNB

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling the delivery of life-changing medicines using its LNC platform technology. The firm's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins, and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable.

CEO

Jerome D. Jabbour

CEOJerome D. Jabbour

Employees

Employees31

Headquarters

Bedminster, New Jersey

HeadquartersBedminster, New Jersey

Founded

2013

Founded2013

Employees

Employees31

MTNB Key Statistics

Market cap

126.65M

Market cap126.65M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

339.30K

Average volume339.30K

High today

$0.6299

High today$0.6299

Low today

$0.5602

Low today$0.5602

Open price

$0.6299

Open price$0.6299

Volume

1.33M

Volume1.33M

52 Week high

$1.16

52 Week high$1.16

52 Week low

$0.49

52 Week low$0.49

MTNB Earnings

-$0.03

-$0.02

-$0.01

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 8, After Hours

ActualExpected Mar 8, After Hours